Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05694598 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Mar 1, 2025 to Sep 13, 2024
    • Study completion date: Sep 1, 2025 to Sep 13, 2028
    • Start date changed from estimate of Mar 1, 2023 to Mar 27, 2023
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Multicenter, Open-Label, Non-Randomized, Uncontrolled Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.
Trial Details
NCT Number NCT05694598
Lead Sponsor Shanghai Vitalgen BioPharma Co., Ltd.
Conditions
(from sponsor)		 Bietti Crystalline Dystrophy
Related terms Bietti Crystalline Dystrophy
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov